药明巨诺-B(02126)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02126 药明巨诺-B

未开盘 01-30 16:08:02

2.420

-0.130

-5.10%

最高2.550	最低2.420	成交量98.60万
今开2.550	昨收2.550	日振幅5.10%
总市值10.07亿	流通市值10.07亿	总股本4.16亿
成交额241.09万	换手率0.24%	流通股本4.16亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02126","market":"HK","secType":"STK","nameCN":"药明巨诺-B","latestPrice":2.42,"timestamp":1769760482349,"preClose":2.55,"halted":0,"volume":985975,"delay":0,"changeRate":-0.05098039215686271,"floatShares":416000000,"shares":416000000,"eps":-1.42789,"marketStatus":"未开盘","change":-0.13,"latestTime":"01-30 16:08:02","open":2.55,"high":2.55,"low":2.42,"amount":2410925,"amplitude":0.05098,"askPrice":2.44,"askSize":4000,"bidPrice":2.42,"bidSize":138000,"shortable":0,"etf":0,"ttmEps":-1.631149,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769995800000},"marketStatusCode":0,"adr":0,"listingDate":1604332800000,"exchange":"SEHK","adjPreClose":2.55,"openAndCloseTimeList":[[1769736600000,1769745600000],[1769749200000,1769760000000]],"volumeRatio":0.7088755481807147,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02126","defaultTab":"news","newsList":[{"id":"2606713272","title":"药明巨诺-B01月28日主力净流出40.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2606713272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606713272?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:16","pubTimestamp":1769588162,"startTime":"0","endTime":"0","summary":"01月28日, 药明巨诺-B股价跌1.97%，报收2.49元，成交金额339.6万元，换手率0.32%，振幅3.15%，量比1.09。药明巨诺-B今日主力资金净流出40.3万元，上一交易日主力净流出0万元。该股近5个交易日下跌7.43%，主力资金累计净流出262.1万元；近20日主力资金累计净流出566.1万元，其中净流出天数为12日。该股主力净额占比0.04%，港股市场排名2569/2707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128162746a6b67253&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128162746a6b67253&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","BK1574","02126"],"gpt_icon":0},{"id":"2606256022","title":"药明巨诺-B盘中异动 股价大跌5.30%报2.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606256022","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606256022?lang=zh_cn&edition=full","pubTime":"2026-01-26 10:54","pubTimestamp":1769396093,"startTime":"0","endTime":"0","summary":"2026年01月26日早盘10时54分，药明巨诺-B股票出现波动，股价大幅下挫5.30%。截至发稿，该股报2.500港元/股，成交量114.7万股，换手率0.28%，振幅5.30%。资金方面，该股资金流入32.7135万港元，流出245.551万港元。药明巨诺-B股票所在的生物技术行业中，整体跌幅为1.93%。其相关个股中，北海康成-B、中生北控生物科技、维亚生物涨幅较大，振幅较大的相关个股有中生北控生物科技、维亚生物、来凯医药-B，振幅分别为17.28%、15.35%、15.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126105453a6ac3fa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126105453a6ac3fa4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02126","BK1583"],"gpt_icon":0},{"id":"2605414969","title":"药明巨诺-B盘中异动 大幅下挫5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605414969","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605414969?lang=zh_cn&edition=full","pubTime":"2026-01-22 10:23","pubTimestamp":1769048618,"startTime":"0","endTime":"0","summary":"2026年01月22日早盘10时23分，药明巨诺-B股票出现异动，股价大幅下挫5.20%。截至发稿，该股报2.550港元/股，成交量33.55万股，换手率0.08%，振幅5.58%。药明巨诺-B股票所在的生物技术行业中，整体跌幅为0.89%。其相关个股中，药捷安康-B、瑞博生物-B、维亚生物涨幅较大，振幅较大的相关个股有中生北控生物科技、药捷安康-B、维亚生物，振幅分别为27.63%、14.75%、6.84%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122102338a447cc16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122102338a447cc16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1574","02126"],"gpt_icon":0},{"id":"2605638120","title":"药明巨诺-B01月20日遭主力抛售34.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605638120","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605638120?lang=zh_cn&edition=full","pubTime":"2026-01-20 16:15","pubTimestamp":1768896924,"startTime":"0","endTime":"0","summary":"01月20日, 药明巨诺-B股价跌4.33%，报收2.65元，成交金额527.0万元，换手率0.48%，振幅7.94%，量比0.89。药明巨诺-B今日主力资金净流出34.7万元，上一交易日主力净流出67.8万元。该股近5个交易日下跌9.83%，主力资金累计净流出159.5万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出207.3万元，其中净流出天数为11日。该股主力净额占比0.03%，港股市场排名2542/2709。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120162209a4402c23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120162209a4402c23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02126","BK1574","BK1583"],"gpt_icon":0},{"id":"2604568153","title":"药明巨诺-B盘中异动 急速下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604568153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604568153?lang=zh_cn&edition=full","pubTime":"2026-01-19 11:28","pubTimestamp":1768793314,"startTime":"0","endTime":"0","summary":"2026年01月19日早盘11时28分，药明巨诺-B股票出现异动，股价快速下跌5.14%。截至发稿，该股报2.770港元/股，成交量65.8万股，换手率0.16%，振幅2.74%。资金方面，该股资金流入25.1595万港元，流出147.203万港元。药明巨诺-B股票所在的生物技术行业中，整体跌幅为3.92%。药明巨诺-B公司简介：药明巨诺(开曼)有限公司是一家主要从事细胞免疫治疗产品的研究及开发、生产及上市的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119112834a72aa27f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119112834a72aa27f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1574","02126"],"gpt_icon":0},{"id":"2603995236","title":"药明巨诺-B(02126)授出260万份购股权及65万个受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2603995236","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603995236?lang=zh_cn&edition=full","pubTime":"2026-01-16 20:53","pubTimestamp":1768568029,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明巨诺-B(02126)发布公告，于2026年1月16日，公司根据2020年10月14日采纳的公司首次公开发售后激励计划的条款将合共260万份购股权;及根据2020年10月14日采纳的公司首次公开发售后受限制股份单位计划将合共65万个受限制股份单位授予公司四名承授人。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394056.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1583","BK1161","02126"],"gpt_icon":0},{"id":"2603662846","title":"盟科药业聘任85后郭萃为财务负责人，曾任职药明巨诺","url":"https://stock-news.laohu8.com/highlight/detail?id=2603662846","media":"瑞财社","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603662846?lang=zh_cn&edition=full","pubTime":"2026-01-14 09:23","pubTimestamp":1768353801,"startTime":"0","endTime":"0","summary":"瑞财经 刘治颖1月13日，盟科药业-U公告，经公司总经理提名、董事会提名委员会资格审查无异议，公司董事会同意聘任卢亮为公司副总经理、郭萃为公司财务负责人。2020年12月至2025年11月，任公司职工代表监事、监事会主席。2025年7月至今，担任公司董事会办公室高级经理。奉竹女士已取得上海证券交易所科创板上市公司董事会秘书任职培训证明。2025年前三季度，盟科药业营业收入实现1.04亿元，同比增长6.58%，归母净亏损1.94亿元，同比收窄33.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114092810a4c0d8fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114092810a4c0d8fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1574","02126"],"gpt_icon":0},{"id":"2603950262","title":"A股、港股医药股今日大涨，这些利好因素在刺激","url":"https://stock-news.laohu8.com/highlight/detail?id=2603950262","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603950262?lang=zh_cn&edition=full","pubTime":"2026-01-13 11:37","pubTimestamp":1768275475,"startTime":"0","endTime":"0","summary":"1月13日上午，A股以及港股的医药股集体出现走强趋势。当前，已有重磅对外授权交易揭晓。这笔交易刺激了A股、港股市场中的一些双抗概念股股价大涨，1月13日上午，宜明昂科港股股价盘中涨幅一度超过10.10%；三生国健A股股价涨幅也超过4%。同样，A股以及港股的医药外包股齐齐出现股价大涨局面，如药明康德A股跟港股上午盘中股价涨幅超过6%；药明生物股价涨幅也超过5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113113932a4bcec89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113113932a4bcec89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0516423174.USD","LU0516423091.SGD","02269","LU1969619763.USD","LU3063872942.SGD","09995","LU0516422440.USD","BK1576","LU0359201612.USD","LU0516422366.SGD","LU0417516902.SGD","LU1688375341.USD","SG9999002562.SGD","LU0320764599.SGD","LU1794554557.SGD","LU0181495838.USD","LU0359202008.SGD","LU0516422952.EUR","LU0417516738.SGD","LU0327786744.USD","BK1515","LU2039709279.SGD","LU0708995583.HKD","LU0819121731.USD","LU0823426308.USD","BK1161","LU1242518857.USD","09939","LU0588546209.SGD","02179","LU1880383366.USD","BK1574","LU1720050803.USD","LU0856984785.SGD","LU0039217434.USD","LU0456827905.SGD","LU0051755006.USD","LU0823426480.USD","02616","LU0043850808.USD","LU0348825331.USD","LU0052750758.USD","02126","LU0307460666.USD","IE00B0JY6N72.USD","LU1242518931.SGD","LU0979878070.USD","LU2328871848.SGD","BK1610","01541"],"gpt_icon":0},{"id":"2601364046","title":"药明巨诺-B01月08日遭主力抛售6.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601364046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601364046?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:15","pubTimestamp":1767860132,"startTime":"0","endTime":"0","summary":"01月08日, 药明巨诺-B股价跌1.75%，报收2.80元，成交金额633.0万元，换手率0.55%，振幅4.56%，量比1.65。药明巨诺-B今日主力资金净流出6.4万元，连续3日净流出，上一交易日主力净流出5.4万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为62.50%，平均跌幅为7.39%。该股近5个交易日上涨9.96%，主力资金累计净流出60.2万元；近20日主力资金累计净流出5.8万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108162003a4ab29d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108162003a4ab29d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","BK1161","02126"],"gpt_icon":0},{"id":"2601899403","title":"药明巨诺-B01月06日主力净流出29.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2601899403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601899403?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:15","pubTimestamp":1767687345,"startTime":"0","endTime":"0","summary":"01月06日, 药明巨诺-B股价跌1.84%，报收2.67元，成交金额391.9万元，换手率0.35%，振幅6.25%，量比1.28。药明巨诺-B今日主力资金净流出29.6万元，上一交易日主力净流入5.9万元。该股近5个交易日上涨6.80%，主力资金累计净流出0.2万元；近20日主力资金累计净流入6.0万元，其中净流入天数为5日。该股主力净额占比0.03%，港股市场排名2566/2708。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106161951a4a2782d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106161951a4a2782d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02126","BK1583","BK1574"],"gpt_icon":0},{"id":"2600601347","title":"新增114种药品、覆盖肿瘤等领域，湖南落地执行最新医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2600601347","media":"湖南日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600601347?lang=zh_cn&edition=full","pubTime":"2026-01-03 16:48","pubTimestamp":1767430080,"startTime":"0","endTime":"0","summary":"新版目录新增114种药品，精准覆盖肿瘤、罕见病等关键领域，首推的商保创新药目录与基本医保目录形成保障互补。114个药品新增纳入目录，覆盖肿瘤等领域本次国家目录调整，共有114个药品新增纳入目录，29个药品调出目录，部分药品从协议期内调入常规目录，部分药品增补了规格或调整了限定支付范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260103170328a4971f34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260103170328a4971f34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02196","BK1515","BK1593","BK1574","06978","BK1161","02126"],"gpt_icon":0},{"id":"2595074907","title":"药明巨诺-B12月30日获主力加仓46.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595074907","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595074907?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:15","pubTimestamp":1767082530,"startTime":"0","endTime":"0","summary":"12月30日，药明巨诺-B股价收平报2.50元，成交金额182.3万元，换手率0.17%，振幅5.60%，量比0.70。药明巨诺-B今日主力资金净流入46.1万元，上一交易日主力净流入2.2万元。该股近5个交易日下跌7.75%，主力资金累计净流入65.3万元；近20日主力资金累计净流入45.6万元，其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230161732a6e06a41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230161732a6e06a41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","BK1161","02126"],"gpt_icon":0},{"id":"2592993011","title":"药明巨诺-B12月17日主力净流入95.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2592993011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592993011?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:15","pubTimestamp":1765959337,"startTime":"0","endTime":"0","summary":"12月17日，药明巨诺-B股价收平报2.82元，成交金额241.8万元，换手率0.21%，振幅2.48%，量比1.05。药明巨诺-B今日主力资金净流入95.5万元，上一交易日主力净流出0万元。该股近5个交易日下跌8.14%，主力资金累计净流入79.5万元；近20日主力资金累计净流出19.7万元，其中净流出天数为5日。该股主力净额占比0.08%，港股市场排名74/2690。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217161817a6ad1232&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217161817a6ad1232&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02126","BK1583"],"gpt_icon":0},{"id":"2592993048","title":"年薪300万元！前恒瑞高管加入药明巨诺","url":"https://stock-news.laohu8.com/highlight/detail?id=2592993048","media":"张通社","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592993048?lang=zh_cn&edition=full","pubTime":"2025-12-16 18:20","pubTimestamp":1765880452,"startTime":"0","endTime":"0","summary":"张通社 zhangtongshe.com｜立足张江，面向上海，服务科创｜近日，药明巨诺发布公告，任命田丰为公司行政总裁及执行董事。初始任期为3年，田丰有权收取人民币300万元的年度基本薪酬及酌情绩效花红、股份奖励及其他实物福利。ZHANG TONG SHE同时，药明巨诺还宣布任命公司非执行董事刘诚博士为董事会主席。在加入药明巨诺之前，于2023年5月至2025年12月，其在长春金赛药业担任肿瘤事业部总经理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216191623a4524125&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216191623a4524125&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02126","BK1161","BK1583"],"gpt_icon":0},{"id":"2591024606","title":"药明巨诺-B12月15日主力净流出16.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2591024606","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591024606?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:16","pubTimestamp":1765786566,"startTime":"0","endTime":"0","summary":"12月15日, 药明巨诺-B股价跌3.93%，报收2.93元，成交金额213.0万元，换手率0.17%，振幅3.93%，量比0.55。药明巨诺-B今日主力资金净流出16.0万元，上一交易日主力净流出0万元。该股近5个交易日下跌9.85%，主力资金累计净流出98.4万元；近20日主力资金累计净流出291.9万元，其中净流出天数为6日。该股主力净额占比0.01%，港股市场排名2442/2689。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215162327a6a44a6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215162327a6a44a6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02126","BK1574","BK1583"],"gpt_icon":0},{"id":"2591960609","title":"12月以来，药明巨诺、恒瑞医药、南新制药等大批药企高管变动！","url":"https://stock-news.laohu8.com/highlight/detail?id=2591960609","media":"制药网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591960609?lang=zh_cn&edition=full","pubTime":"2025-12-15 15:54","pubTimestamp":1765785283,"startTime":"0","endTime":"0","summary":"年末，国内医药行业高管变动进入密集期。根据梳理，近期，多家药企发布高管变动公告，涉及药明巨诺、恒瑞医药、南新制药、康恩贝等。12月10日，南新制药发布公告，宣布原非独立董事彭程因个人原因辞去相关职务，副总经理兼财务总监李亮因工作调整辞任。除了以上企业，12月以来，百奥赛图、维康药业、复锐医疗也有高管因个人原因、工作调动等原因辞任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216085448a6a70ec0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216085448a6a70ec0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359201885.HKD","01276","BK1574","BK1161","LU1023057109.AUD","LU0359202008.SGD","LU2543165471.USD","LU0359201612.USD","02126","BK1583","BK1191"],"gpt_icon":0},{"id":"2591631174","title":"药明巨诺换帅，新管理层迎战CAR-T市场机遇与挑战","url":"https://stock-news.laohu8.com/highlight/detail?id=2591631174","media":"21世纪经济报道","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591631174?lang=zh_cn&edition=full","pubTime":"2025-12-12 20:41","pubTimestamp":1765543270,"startTime":"0","endTime":"0","summary":"药明巨诺董事会在2025年9月批准的、拟授予刘敏的超420万份购股权，亦同步宣告取消。为保障管理过渡期间的运营稳定，药明巨诺表示，在田丰正式履职前，现有管理层将暂代行政总裁职责，确保公司日常运营平稳有序。新任董事会主席刘诚同样具备逾二十年行业深耕经验，药明巨诺公告称其在生物制药领域手握超300项专利及公开专利申请，在全球CAR-T领域专利排名中位居前列。药明巨诺管理层更换之际，正值国内CAR-T药物迎来商保支付的关键突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512122043399539f570&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512122043399539f570&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1161","BK1583","06978","BK1574"],"gpt_icon":0},{"id":"2590547100","title":"药明巨诺-B(02126)：田丰将获委任为行政总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=2590547100","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590547100?lang=zh_cn&edition=full","pubTime":"2025-12-12 07:39","pubTimestamp":1765496371,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明巨诺-B 发布公告，田丰先生(田先生)将获委任为本公司行政总裁及执行董事，自2025年12月29日起生效。董事会谨此宣布任命刘博士接替刘先生担任上市规则第3.05条规定的本公司授权代表， 自2025年12月12日起生效。董事会进一步宣布，田先生将获委任为授权代表以接替刘博士，自2025年12月29日起生效。连同吴女士，自2025年12月29日起，本公司授权代表为田先生及吴女士。取消2025年9月授出已经刘先生同意。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380669.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02126","BK1161","BK1574","BK1583"],"gpt_icon":0},{"id":"1168817508","title":"药明巨诺-B - 冯天将被任命为首席执行官兼执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1168817508","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168817508?lang=zh_cn&edition=full","pubTime":"2025-12-12 07:30","pubTimestamp":1765495811,"startTime":"0","endTime":"0","summary":"药明巨诺-B - 冯天将被任命为首席执行官兼执行董事","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","BK1574","02126"],"gpt_icon":0},{"id":"2589336107","title":"药明巨诺-B(02126)：在第67届美国血液学会年会上公布JWCAR201 IIT研究数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2589336107","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589336107?lang=zh_cn&edition=full","pubTime":"2025-12-08 17:40","pubTimestamp":1765186830,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明巨诺-B 发布公告，宣布在第67届美国血液学会年会上公布JWCAR201的IIT研究数据。JWCAR201是药明巨诺自主研发的靶向CD19/CD20的自体CAR-T产品。截至2025年10月30日，本研究已入组的7例受试者完成了JWCAR201回输，初步完成了三个剂量组的安全性，疗效以及药代和药效动力学的探索。本研究安全性结果表明，JWCAR201治疗r/r DLBCL安全可控。基于以上研究结果，公司认为JWCAR201疗效卓越，且整体安全性良好、不良反应可控，展现出了快速推进至IND阶段的巨大潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378853.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明巨诺-B(02126)：在第67届美国血液学会年会上公布JWCAR201 IIT研究数据","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02126","BK1574","BK1583"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0833},{"period":"1month","weight":-0.0359},{"period":"3month","weight":-0.3046},{"period":"6month","weight":-0.501},{"period":"1year","weight":0.741},{"period":"ytd","weight":-0.0359}],"compareEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":0.0685},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.1175},{"period":"1year","weight":0.3541},{"period":"ytd","weight":0.0685}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明巨诺（开曼）有限公司是一家主要从事细胞免疫治疗产品的研究及开发、生产及上市的公司。该公司建立了一个细胞免疫治疗产品开发的一体化平台以及一条涵盖血液恶性肿瘤、实体瘤及自身免疫性疾病的产品管线。该公司的主要产品倍诺达是该公司在Juno（一家百时美施贵宝的公司）的嵌合抗原受体T细胞（CAR-T）细胞工艺平台的基础上，自主开发的一款靶向CD19的自体CAR-T细胞免疫治疗产品。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.01554},{"month":2,"riseRate":0.8,"avgChangeRate":0.129974},{"month":3,"riseRate":0,"avgChangeRate":-0.16747},{"month":4,"riseRate":0.2,"avgChangeRate":-0.051907},{"month":5,"riseRate":0.6,"avgChangeRate":0.078145},{"month":6,"riseRate":0.4,"avgChangeRate":0.023117},{"month":7,"riseRate":0.4,"avgChangeRate":0.091377},{"month":8,"riseRate":0,"avgChangeRate":-0.160963},{"month":9,"riseRate":0.2,"avgChangeRate":-0.071154},{"month":10,"riseRate":0.2,"avgChangeRate":-0.118018},{"month":11,"riseRate":0.4,"avgChangeRate":0.158609},{"month":12,"riseRate":0.5,"avgChangeRate":-0.061814}],"exchange":"SEHK","name":"药明巨诺-B","nameEN":"JW THERAP-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明巨诺-B(02126)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明巨诺-B(02126)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明巨诺-B,02126,药明巨诺-B股票,药明巨诺-B股票老虎,药明巨诺-B股票老虎国际,药明巨诺-B行情,药明巨诺-B股票行情,药明巨诺-B股价,药明巨诺-B股市,药明巨诺-B股票价格,药明巨诺-B股票交易,药明巨诺-B股票购买,药明巨诺-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明巨诺-B(02126)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明巨诺-B(02126)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}